Novartis NVS announced that the FDA granted Breakthrough Therapy designation to its pipeline candidate, ianalumab for the ...

The number of systemic anti-inflammatory therapies for dermatologic diseases in children is expected to grow in 2026.

Systemic therapy is often given late due to optimism bias, treatment momentum, and difficulty in end-of-life conversations, leading to increased hospitalizations and ICU admissions. MD Anderson Cancer ...

Serial metastasis-directed radiotherapy extended time off systemic therapy while maintaining favorable progression-free and overall survival in patients with oligometastatic clear-cell renal cell ...

The results of this study highlight the need for more research into how treatment at the end of life is shaped by oncologists’ unique treatment propensities, according to researchers. Oncologists’ ...

Enhancement of 30-day acute care event prediction model following outpatient chemotherapy using vital signs, lab results, and advanced machine learning: A comparative analysis. This is an ASCO Meeting ...

Please provide your email address to receive an email when new articles are posted on . One specialist highlighted cases in which systemic treatments, such as corticosteroids, are better. Another ...

Select patients with oligometastatic ccRCC might be managed with a period of metastasis-directed therapy alone. Serial metastasis-directed radiation therapy may delay systemic therapy in clear cell ...